Last week the Michigan Department of Health and Human Services told FOX 2 that the state has been allocated up to nearly 200,000 Pfizer doses and just a little over 70,000 Moderna doses for initial orders.
"I'm hoping that a more omicron-specific vaccine will give you even more protection against the serious issues, but also give you better protection against actual infection," Sims said.
Drug makers are working to create a COVID-19 booster vaccine that targets the original strain as well as the Omicron sub-variants. With that coming, should you get a booster now or wait?
Researchers found that while COVID-19 booster vaccinations create a strong antibody response against omicron initially, within three months post-boost, those levels decrease.
Health officials say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax.
Kids should be able to get the vaccine at Henry Ford Health by next week.
With the CDC's final sign-off, roughly 18 million children under 5 will be eligible for COVID-19 shots beginning next week.
If the CDC grants the green light, the vaccine could be available as soon as next week.
COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.
An FDA advisory panel endorsed on Tuesday Moderna's COVID-19 vaccine for teenagers and school-aged children.
The Food and Drug Administration's outside panel of advisers will meet on June 14-15 to evaluate the Pfizer and Moderna shots for younger children.
Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
Children under 5 are the only group in the U.S. not yet eligible for a COVID-19 vaccination.
He was caught at a vaccination center when he showed up for a COVID-19 shot for the second day in a row.
President Joe Biden received his second COVID-19 booster while asking Congress for more funding and rolling out a new website.
U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
Drugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.
Pfizer is expected to request authorization for a fourth COVID-19 vaccine dose for seniors in a move to provide extra protection to the over-65 population that has been hit hardest by the pandemic.
Researchers say understanding the link between parents and their kids is key to understanding the hesitancy of receiving a COVID-19 vaccine.
The decision was based on a study of 24,000 adults that found the vaccine was 71 percent effective at preventing COVID-19 — although that was before the omicron variant emerged. Side effects were mild, including fever and fatigue.